Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statements Details

v3.19.1
Condensed Consolidated Financial Statements Details
3 Months Ended
Mar. 31, 2019
Condensed Consolidated Financial Statements Detail [Abstract]  
Condensed Consolidated Financial Statements Details

3. Condensed Consolidated Financial Statements Details

Long-term Equity Securities

As of March 31, 2019 and December 31, 2018, long-term equity securities consisted of an investment in Rezolute’s common stock of $1.1 million and $0.4 million, respectively (see Note 4). The Company recognized a gain of $0.7 million due to the change in fair value of its investment in Rezolute’s common stock in other income, net line item of the condensed consolidated statement of operations and comprehensive income for the three months ended March 31, 2019. There is no comparable gain or loss recognized for the three months ended March 31, 2018 as the long-term equity securities were received in the second quarter of 2018.

Accrued and Other Liabilities  

Accrued and other liabilities consisted of the following (in thousands):

 

 

March 31,

 

 

December 31,

 

 

 

2019

 

 

2018

 

Accrued legal and accounting fees

 

$

181

 

 

$

396

 

Accrued restructuring

 

 

 

 

 

1,361

 

Accrued incentive compensation

 

 

209

 

 

 

152

 

Liability related to sublease

 

 

 

 

 

84

 

Accrued payroll and other benefits

 

 

127

 

 

 

155

 

Other

 

 

281

 

 

 

234

 

Total

 

$

798

 

 

$

2,382

 

Net Income (Loss) Per Share Available to Common Stockholders

The following is a reconciliation of the numerator (net income or loss) and the denominator (number of shares) used in the calculation of basic and diluted net income (loss) per share available to common stockholders (in thousands):

 

Three Months Ended March 31,

 

 

 

2019

 

 

2018

 

 

Numerator

 

 

 

 

 

 

 

 

Net income (loss)

$

3,233

 

 

$

(3,806

)

 

Less: Allocation of undistributed earnings to participating securities

 

(1,352

)

 

 

 

 

Net income (loss) available to common stockholders, basic

 

1,881

 

 

 

(3,806

)

 

Add: Adjustments to undistributed earnings allocated to participating securities

 

54

 

 

 

 

 

Net income (loss) available to common stockholders, diluted

$

1,935

 

 

$

(3,806

)

 

 

 

 

 

 

 

 

 

 

Denominator

 

 

 

 

 

 

 

 

Weighted average shares used in computing basic net income (loss)

   per share available to common stockholders

 

8,706

 

 

 

8,313

 

 

Effect of dilutive stock options

 

618

 

 

 

 

 

Weighted average shares used in computing diluted net income (loss)

   per share available to common stockholders

 

9,324

 

 

 

8,313

 

 

Basic net income (loss) per share available to common stockholders

$

0.22

 

 

$

(0.46

)

 

Diluted net income (loss) per share available to common stockholders

$

0.21

 

 

$

(0.46

)

 

Potentially dilutive securities are excluded from the calculation of diluted net income (loss) per share available to common stockholders if their inclusion is anti-dilutive. The following table shows the weighted-average outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net income (loss) per share available to common stockholders (in thousands):

 

Three Months Ended March 31,

 

 

 

2019

 

 

2018

 

 

Convertible preferred stock

 

 

 

 

5,003

 

 

Common stock options and RSUs

 

830

 

 

 

1,645

 

 

Warrants for common stock

 

25

 

 

 

17

 

 

Total

 

855

 

 

 

6,665